Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$48.6 n/a | n/a%
11/21/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 48.60
52 Week High 93.33
52 Week Low 35.33
Avg. Daily Vol. (Mil) 0.87
Beta (3 year) 2.52
Share Related Items
Mkt Cap (Mil) 1,650.67
Shares Out (Mil) 33.96
Float (Mil) 20.94
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 16.90
Current Ratio 17.00
LT Debt/ Equity 0.74
Total Debt / Equity 0.74
Valuation Ratios
Price Earnings n.a.
Price/Sales 121.15
Price/Book 4.25
Price/Cash Flow -12.60
Per Share Data
Earnings -4.05
Sales 0.40
Book Value 11.43
Cash Flow -3.84
Business Summary
Clovis Oncology Inc is a biopharmaceutical company. The Company is engaged in acquiring, developing and commercializing anti-cancer treatments in the United States, Europe and other international markets.
General Information
2525 28th Street
Suite 100
Boulder, CO 80301
www.clovisoncology.com
Industry : Drugs
Sector: Health Care
Employees: 74
CEO: Patrick J. Mahaffy
Short Interest
Current Month (Mil) 5.47
Previous Month (Mil) 5.26
Short Interest Ratio (Days) 6.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -16.20
Return on Investments -19.90
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CLVS

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter